Michael R. McKellar, BA
Advertisement
Articles by Michael R. McKellar, BA
This commentary discusses why antibiotics and the treatment of infectious diseases present a special case for pharmaceutical development, pricing, and appropriate utilization.
Advertisement
Latest Updated Articles
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: April 23rd 2014 | Updated:
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: March 18th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
5 Things to Know About the Oral GLP-1 Era
5
